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Abstract 
Detailed polychlorinated biphenyl (PCB) signatures and chiral Enantiomer Fractions (EFs) of 
CB-95, CB-136 and CB-149 were measured for 30 workers at a transformer dismantling 
plant. This was undertaken to identify sources of exposure and investigate changes to the 
PCB signature and EFs over different exposure periods. Approximately 1.5 g of serum was 
extracted and PCB signatures were created through analysis by comprehensive two-
dimensional gas chromatography with time-of-flight mass spectrometry (GC×GC-TOFMS) 
and EFs calculated following analysis by gas chromatography with high resolution mass 
spectrometry (GC-HRMS). A total of 84 PCBs were identified in the serum samples with 
concentrations of the 7 indicator PCBs ranging from 11 - 350 ng g-1 of serum (1.2 - 39 µg g-1 
lipid). The PCB signatures were interpreted using principal component analysis (PCA) which 
was able to distinguish workers with background or recent minimal exposure from those with 
prolonged occupational exposure. Occupationally exposed individuals had a similar PCB 
profile to Aroclor A1260. However, individuals with prolonged exposure had depleted 
proportions of several PCB congeners that are susceptible to metabolism (CB-95, CB-101 
and CB-151) and elevated proportions of PCBs that are resistant to metabolism (CB-74, CB-
153, CB-138 and CB-180). The results also identified a third group of workers with elevated 
proportions of CB-28, CB-60, CB-66, CB-74, CB-105 and CB-118 who appeared to have 
been exposed to an additional source of PCBs. The results show near complete removal of the 
CB-95 E2 enantiomer in some samples, indicating that bioselective metabolism or 
preferential excretion of one enantiomer occurs in humans. By considering PCB 
concentrations along with detailed congener specific signatures it was possible to identify 
different exposure sources, and gain an insight into both the magnitude and duration of 
exposure. 
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Highlights 
 Eighty four different PCBs detected in human serum samples 
 PCB signatures used to distinguish recent and prolonged exposure 
 PCB signatures used to identify different sources of exposure 
 Near complete removal of the CB-95 E2 enantiomer recorded in some humans 
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1 Introduction 
Polychlorinated biphenyls (PCBs) are a group of 209 chlorinated organic compounds that 
were widely used throughout the 20th century. While PCBs have been largely phased out of 
commercial/industrial use, they remain an important legacy contaminant (O'Sullivan and 
Sandau, 2013). They are highly persistent and can still be found in closed systems in some 
countries, e.g. as dielectric fluids in electrical equipment and transformers. Many of these 
transformers containing PCBs are in the process of being replaced, and this process therefore 
presents the potential of PCB exposure for humans working in dismantling plants. In these 
instances it is important not only to determine the extent of exposure, along with the potential 
risks to human health, but to also establish the source and age date the exposure.  
As PCBs were produced as commercial mixtures, such as Aroclors, each blend has a specific 
congener profile (signature) based on the relative proportions of each PCB in the total 
mixture. This signature can be used to easily distinguish commercial mixtures, however 
environmental investigations involving humans are more complex as there are often multiple 
potential sources of PCB exposure. The signature can be altered by changes such as 
volatilization, dissolution and biodegradation (Jaspers et al., 2013; Johnson et al., 2006). The 
signature in humans can also vary depending on different exposure pathways e.g. oral, 
inhalation or dermal, and can be altered through post uptake processes such as 
biotransformation and elimination (Jaspers et al., 2013; Megson et al., 2013a). If a dominant 
source of exposure can be identified then alterations to this signature from post uptake 
processes such as biotransformation and elimination may provide useful information to 
distinguish between recent and prolonged exposure. The sera of an individual who has been 
historically exposed may contain higher proportions of the PCBs that are more resistant to 
biotransformation and elimination. Due to all of the subtle changes that can occur to the PCB 
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profile, it is imperative that signatures are created using detailed congener specific datasets 
when attempting to identify the source of exposure. Analysis using comprehensive two 
dimensional chromatography has proven to be an excellent technique for this purpose as it is 
able to separate over 190 individual PCB congeners (Focant et al., 2004; Korytar et al., 2006; 
Harju et al., 2003; Zapadlo et al., 2011; Megson et al., 2013b). 
Of the 209 PCBs there are 19 which are predicted to exist as stable atropisomers (Oki, 1983). 
They have a high degree of ortho chlorine substitution which inhibits rotation, and 
asymmetrical meta and para substitution on each biphenyl, resulting in two optical isomers. 
In commercial mixtures both enantiomers are produced in equal proportions; however in 
animals, metabolic processes such as enzyme mediated oxidation have been proven to 
preferentially target one stereoisomer, resulting in atropisomeric enrichment (Harrad et al. 
2006; Wong et al., 2002; Wu et al., 2014). Therefore, the sera of an individual who has 
recently been exposed to a commercial PCB mixture may be expected to contain near equal 
proportions of each stereoisomer, whereas the sera of a historically exposed individual may 
show a greater degree of atropisomeric enrichment. However, this signal is likely to be 
complicated by interferences such as other background sources of PCBs. 
The goal of this study was to determine if PCB signatures and enantiomer fractions could be 
used to identify the exposure source and distinguish between recent and prolonged exposure 
periods for 30 workers at a transformer dismantling plant. 
2 Experimental 
2.1 Sample collection  
Samples of whole blood were collected from 30 people working at a transformer dismantling 
plant. Samples were obtained from workers performing a range of different roles at the plant, 
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including workers on the dismantling floor who were likely to have had direct contact with 
PCBs and those who were not expected to have had any direct contact with PCBs due to their 
job roles. Samples were obtained from employees who had been working at the plant from 3 - 
21 years. However, information on occupation and length of time at the plant was not 
available for three participants (id no. S028, S029 and S030). A 10 mL sample of whole 
blood was obtained from each worker, the blood was collected in vacutainers, then 
centrifuged and the serum collected and stored at -20 ˚C until analyses, following a reported 
procedure (Focant et al. 2006). All samples were anonymized using a double blind coding 
system between time of sampling and time of analyses to ensure protection of individual 
privacy. 
Total lipid concentrations were determined by enzymatic analysis which was performed by a 
sub-contractor clinical laboratory on a dedicated 2 mL serum sub-sample. Four types of lipids 
were targeted and measured; triglycerides, total cholesterol, non-esterified (free) cholesterol, 
and phospholipids. Sample sizes were as follows: triglycerides (2 µL), total cholesterol (2 
µL), non-esterified (free) cholesterol (50 µL), and phospholipids (20 µL). Total lipid 
concentrations were estimated using the summation method of Akins et al. (1989). The total 
lipid content was expressed in g L-1. For the inter-conversion of volumetric and gravimetric 
data, a value of 1.026 g mL-1 for serum specific gravity was used.  
2.2 Sample preparation 
All reagents required for extraction and clean-up were sourced specifically for dioxin, furan 
and PCB analysis or of the closest grade available of similar quality. Approximately 1.5 g of 
serum was accurately weighed (to 4 decimal places) and transferred to a vial and 5 µL of 
13C12 labelled CB-60, CB-127 and CB-159 at a concentration of 100 pg µL
-1 (CIL-EC-5370 
EN-1948-4 PCB sampling standard) was added to determine recovery. A volume of formic 
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acid equal to the mass of the sample was added to the serum followed by the same volume of 
high purity water. During each addition the solution was vortexed and allowed to degas for 
several minutes. The whole extract was then applied to a C18 SPE cartridge (1 g / 6 mL) and 
the PCBs were eluted with hexane. The eluent was treated using EPA method 3665A 
sulphuric acid / permanganate clean-up followed by EPA method 3620 Florisil clean-up. 
Extracts were reduced to approximately 50 µL by nitrogen evaporation and 100 µL of 13C12 
labelled PCBs (CIL-EC-5367 CDC PCB Spiking Standard), each at a concentration of 7.5 pg 
µL-1, were added. Extracts were left overnight to evaporate to incipient dryness (the spiking 
standard contained a dodecane keeper). Samples were reconstituted with 10 µL of hexane 
prior to analysis. 
2.3 Congener specific analysis by GC×GC-TOFMS  
Analysis was conducted based on the method described by Megson et al. (2013b) which is 
summarised below. Samples were analysed using a time-of-flight mass spectrometer (LECO, 
St. Joseph, MI Pegasus 4D) coupled to a two dimensional gas chromatograph (Agilent 
Technologies 7890A) equipped with a thermal modulator (LECO, St. Joseph, MI). The gas 
chromatograph was fitted with an Rtx-PCB (60 m x 0.18 mm x 0.18 µm) 1D column and an 
Rxi-17 Sil MS (1.5 m x 0.18 mm x 0.18 µm) 2D column. One µL of sample was injected in 
splitless mode.  
Procedural blanks were prepared for each batch of 8 samples. Contamination with CB-11 was 
identified in the blanks and so this congener was excluded from the results. All samples were 
spiked with two sets of 13C12 labelled internal standards which were used to quantify PCB 
concentrations and calculate recovery. Quantification was undertaken through isotope 
dilution; calibration data was produced for 42 of the most commonly encountered congeners 
(CIL-EC-4133 DSJ PCB Mixture). Quantification of other congeners present in the samples 
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was undertaken using the calibration data from the closest eluting calibrated congener with 
the same level of chlorination. Recovery for all samples was within the accepted range 
specified by EPA method 1668C (10 % to 145 %), the mean recovery was 55 % (± 16 %; 1σ). 
Concentrations were recovery corrected and lipid normalised and reported as ng g-1 lipid 
weight. The instrument limit of detection (LOD) was estimated empirically using the 
calibration standard mixtures, LODs for CB-18 and CB-206 were calculated at a 
concentration of at 1 and 50 pg μL-1 respectively (LODs for the other 40 PCBs are presented 
in Supplementary Information 2). Accuracy and precision were measured for the sum of the 
European Union 7 indicator congeners (EC7; CB-28, CB-52, CB-101, CB-118, CB-138, CB-
153, CB-180) by analysing a 10 ng µL-1 Aroclor 1248 standard three times. The accuracy of 
the sum of the EC7 congeners for the three samples was 105% (± 0.9%; 1 σ). 
2.4 Chiral analysis by GC-HRMS 
The Enantiomeric Fractions (EFs) of CBs 95, 136 and 149 were analysed according to the 
method of Robson and Harrad (2004), using an Agilent 7890 gas chromatograph coupled to a 
Micromass AutoSpec Premier high resolution mass spectrometer (GC-HRMS) tuned to 
greater than 10000 mass resolution. The two most abundant isotopes of each enantiomer were 
recorded in Selected Ion Recording Mode (SIR). This was m/z 325.88040 and 327.87750 for 
CB 95 and m/z 359.84150 and 361.83850 for CBs 136 and 149. These PCBs were chosen 
because they are; (a) able to be baseline separated on the Chirasil-Dex column, (b) free from 
any co-eluting congeners that may bias the results and (c) normally present in the 
environment in high enough concentrations to be accurately measured. 
The chromatographic performance of the method was assessed prior to each run of 8 samples 
by analysing a 1:1:1 mixture of Aroclors 1248, 1252 and 1260.  
Enantiomeric Fractions were calculated as per Harner et al. (2000). Whereby  
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EF=E1/(E1+E2) 
where E1 equals the first eluting or the (+) enantiomer and E2 the second eluting enantiomer.  
Samples where only accepted for quantitation if the enantiomeric fractions of the three 
atropisomers studied were 0.50 (±0.01) in the Aroclor mixture, the least abundant enantiomer 
of the pair had a signal to noise (S:N) ratio greater than 10:1, the isotope ratios were within 
20% of their theoretical values and the analytical recovery of the sample was greater than 
30%. The instrument LOD was estimated by analysing a standard mixture of CB-95 and CB-
149, LODs were calculated at a concentration of 2.5 pg μL-1 per enantiomer. Procedural 
blanks were prepared for each batch of 8 samples; no chiral PCBs were detected in the blanks 
above the limits of detection. 
3 Results and discussion 
3.1 Concentrations of PCBs in workers at a transformer dismantling plant  
A total of 84 different PCB congeners were identified in the serum of the 30 workers at the 
transformer dismantling plant. Concentrations of the 7 indicator PCBs ranged from 11 - 350 
ng g-1 of serum (1.2 - 39 µg g-1 lipid). Background concentrations of these congeners in 
humans are in the range of 0.1 - 10 ng g-1 serum (0.01 - 1 µg g-1 lipid) (Longnecker, 2001). 
This shows that some workers had close to background exposure whereas others had elevated 
PCB concentrations indicating that they may have been exposed to PCBs through their 
occupation. The PCB concentrations in the different workers are summarised in Table 1. The 
results show that the workers with job roles involving direct contact with PCBs generally had 
higher PCB concentrations than those with no direct contact. The mean concentration of the 
EC7 PCBs in workers with direct contact was 17.2 µg g-1 lipid (±13.0; 1σ) which was 
significantly greater (P-value 0.004) than workers with no direct contact (5.83 µg g-1 lipid 
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(±6.90; 1σ)). However, this was not true for all workers, as a concentration of 21.0 µg g-1 
lipid was recorded in one worker who was believed to have had no direct contact with PCBs. 
PCB concentrations generally increased with the number of years the employee had worked 
with the company (Figure 1A), although this increase was not statistically significant (P-
value of 0.052). However, when PCB concentrations of the 18 workers who were working at 
the dismantling plant with direct contact dismantling transformers were considered, this 
increase was statistically significant (P-value of 0.000) (Figure 1B). Regression was also 
undertaken using the Mann-Kendal test for discrete data which again showed a significant 
increase (P-value of 0.001). Although the PCB concentration is well correlated with the 
number of years an individual has worked at the company it should not be used in isolation as 
proof that occupational exposure has occurred. Higher PCB concentrations have been 
reported in older individuals as a result of accumulation of the more persistent congeners and 
exposure to higher historical background concentrations (Megson et al., 2013a; Quinn and 
Wania 2012). There are also several physiological characteristics, such as body fat, serum 
albumin and age, that can influence the uptake and retention of PCBs along with social 
preferences such as diet and smoking (Axelrad et al., 2009; Brown and Lawton, 2001; Jain 
and Wang, 2011; Weintraub and Birnbaum, 2008). This highlights the importance of looking 
at the specific PCB signature of each individual to determine their exposure source rather 
than relying solely on a total PCB concentration. 
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Figure 1. Relationship between PCB concentration and number of years a worker had 
been with the company. Results are presented for all workers (Figure 1A) and only 
those with direct contact dismantling transformers (Figure 1B).  
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Table 1. PCBs concentrations and enantiomer fractions recorded in workers. DPW = 
dismantling plant worker and DPC = dismantling plant chief, Concentrations are 
presented to 3 significant figures and EFs to 2 decimal places. <LOD = below the limit 
of detection (i.e. S:N ratio <10) 
 
Sample 
ID 
Years 
with the 
company 
Concentration 
in serum 
(ng g-1) 
Lipid corrected 
concentration in 
serum  
(µg g-1 lipid) 
Enantiomer fractions 
 
Per 
sample  
Mean 
[±1 σ] 
CB-95 
Mean 
[±1 σ] 
CB-
136 
Mean 
[±1 σ] 
CB-
149 
Mean 
[±1 σ] 
N
o
 d
ir
e
c
t 
c
o
n
ta
c
t 
S001 19-21 18.4 2.49 
5.83 
[± 6.90] 
0.51 
0.63 
[± 0.14] 
<LOD 
0.44 
[± 0.00] 
0.47 
0.37 
[± 0.08] 
S002 19-21 13.7 1.49 0.74 <LOD <LOD 
S003 10-12 11.2 1.23 0.41 <LOD 0.41 
S004 4-6 29.4 4.08 0.55 <LOD 0.26 
S005 19-21 166 21 0.59 <LOD 0.31 
S006 19-21 86.3 11.1 0.66 0.45 0.39 
S007 19-21 26.6 1.93 0.78 0.44 0.41 
S008 4-6 21 3.32 0.82 <LOD <LOD 
D
ir
e
c
t 
c
o
n
ta
c
t 
S009 10-12 28.4 3.76 
17.2 
[± 13.0] 
0.59 
0.74 
[± 0.11] 
0.45 
0.47 
[± 0.05] 
0.47 
0.36 
[± 0.07] 
S010 13-15 62.8 9.41 0.51 <LOD 0.48 
S011 4-6 73.1 6.53 0.88 0.51 0.37 
S012 7-9 70.1 13.2 0.88 <LOD 0.29 
S013 0-3 27.7 3.37 0.87 0.57 0.44 
S014 10-12 246 36.2 0.87 0.43 0.21 
S015 13-15 163 20.6 0.82 <LOD <LOD 
S016 7-9 138 14.4 0.79 0.47 0.32 
S017 16-18 121 19.4 0.72 0.43 0.30 
S018 16-18 353 38.5 0.66 0.46 0.35 
S019 4-6 16.8 3 0.60 <LOD 0.33 
S020 19-21 300 37.7 0.87 <LOD <LOD 
S021 7-9 95.2 14.2 0.74 <LOD 0.37 
S022 19-21 231 39.3 0.67 0.47 0.35 
S023 13-15 62.5 10.4 0.67 0.43 0.35 
S024 4-6 37.5 4.16 0.82 0.51 0.32 
S025 4-6 23.4 4.05 0.66 <LOD 0.44 
S026 7-9 134 27.3 0.66 <LOD 0.44 
S027 13-15 149 21.2 0.77 <LOD <LOD 
U
n
k
n
o
w
n
 S028 unknown 26.1 3.55  
13.7 
[± 14.6] 
 
0.82 
0.78 
[± 0.15] 
0.52 
0.55 
[± 0.048] 
0.36 
0.35 
[± 0.08] 
S029 unknown 187 30.4 0.91 0.59 0.27 
S030 unknown 50.7 7.14 0.61 <LOD 0.43 
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3.2 Statistical evaluation of PCB signatures 
Fifty four PCBs were consistently detected in > 60% of the samples. These were quantified, 
percent normalised and presented as bar charts to show the PCB signature in each participant 
(Supplementary Information 1). Only three different Aroclor blends were understood to have 
been used in transformers; these were A1242, A1254 and A1260 (Johnson et al., 2006). As 
the dismantling plant was in Europe, transformers were likely to have contained a variety 
manufacturers products from the European market, including Aroclors, Phenoclors, Pyralenes 
and Clophens, however there is a very high degree of similarity in the signature from blends 
with an equivalent chlorine content (Johnson et al., 2006). The signature for the majority of 
workers was visually similar to the signature of A1260 (Supplementary Information 1) which 
provides further evidence to suggest that occupational exposure had occurred. However, 
further assessment was undertaken to confirm if this was the source of exposure or if other 
potential sources were important. 
The PCB signatures of the workers were assessed using principal component analysis (PCA). 
Where a PCB was not detected it was included in the dataset as a ‘0’. As part of the data 
quality check, other values such as LOD/2 were substituted for ‘0’, but these had no 
observable effect on the data output and so the ‘0’s were retained. To reduce any bias from a 
high proportion of non-detects for a specific congener, PCBs that were not detected in over 
60% of samples (i.e. PCBs present in less than 18 out of the 30 samples) were removed from 
the analysis following the guidance of Helsel (2006). This resulted in a dataset of 54 PCBs in 
30 participants. Before performing PCA the data were normalised by transformation to a 
percent metric to remove concentration/dilution effects. The data were then mean centred and 
scaled using a Z-transform (autoscale transform) to prevent high concentration variables from 
dominating the analysis (Johnson et al., 2007). Principal component 1 accounted for 33.1% of 
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the variation and principal component 2 accounted for a further 18.2%. The scores plot is 
presented as Figure 2 and the loadings plot as Figure 3. 
The scores plot (Figure 2) displayed a three end member system, showing that there were 
three groups of workers, each with a different PCB signature. Two of the three groups were 
linked to the duration that the participant had been working at the plant and their job, i.e. 
involving either direct contact with PCBs or only indirect contact. One group may therefore 
represent participants with prolonged occupational exposure and the other group exposure to 
background levels or a recent minimal exposure. However, the third group was comprised of 
participants who all had different ages, jobs and years at the company and may therefore be 
linked to an additional source(s) of exposure. Bar charts were produced to identify 
differences in the PCB signature between the three groups and aid the source identification 
process. Figure 4 displays the signature of A1260 along with the signatures of three 
participants (selected using the PCA scores plot) to represent the three groups. These were; 
participant number S020 who had worked at the plant for 19-21 years (representing a 
prolonged exposure to A1260), participant number S013 who had been at the company for 0-
3 years (representing a recent minimal exposure to A1260), and participant number S021 
(representing a suspected additional exposure source). 
3.3 Source identification and age dating exposure 
3.3.1 Occupational exposure to A1260 
Participants with a negative score on PC1 and PC2 were comprised of workers who had been 
working at the dismantling plant for more than 10 years, with direct contact through 
dismantling transformers. The signatures from these samples is visually similar to the profile 
of A1260 but with depleted proportions of several of the less chlorinated biphenyls, CB-88 & 
95, CB-90 & 101 and CB-151 (Figure 4). These are congeners predominantly containing a 
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phenyl group with un-chlorinated meta and para positions (i.e. 2,5- chlorine substitution), 
which are particularly susceptible to metabolic attack by P450 cytochromes (Letcher et al., 
1999). The signature also contained elevated proportions of CB-74, CB-153, CB-138 and 
CB-180 (Figure 4). These are congeners containing a phenyl group with 2,4,5- substitution 
which are particularly resistant to biotransformation and elimination (Megson et al., 2013a). 
Interestingly this group also included several participants with jobs not believed to involve 
direct exposure, although they had low PCB concentrations their signature was similar to 
A1260. The signature shows that these individuals appear to have been exposed to PCBs 
through occupational exposure, although the total PCB concentrations indicate exposure was 
only minimal. 
3.3.2 Background or recent minimal occupational exposure 
Participants with a positive score on PC2 comprised of workers who had been working at the 
plant for a relatively short period of time (< 6 years), along with those with jobs that did not 
involve direct exposure. All of these individuals contained significantly lower (P-value 0.000) 
EC7 PCB concentrations (mean value of 3.2 µg g-1 lipid (±1.0; 1σ)) than the rest of the 
samples (mean value of 19.1 µg g-1 lipid (±12.2; 1σ)). The signature from this group 
contained higher proportions of several episodic congeners such as CB-8, CB-18, CB-31, 
CB-52 and CB-151 (Figure 3), indicating a recent exposure. The signature also displayed 
slightly elevated proportions of many of the lower chlorinated PCBs that were not present in 
high concentrations in A1260 such as CB-28, CB-74, CB-99 and CB-118 (Figure 4), 
indicating a background exposure (Figure 2). 
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Figure 4. PCB signature for the serum samples obtained from participants S020, S013 
and S021 compared with the signature from A1260.  
3.3.3 Additional inhalation exposure 
In some instances inhalation has proven to be an important PCB exposure pathway 
(DeCaprio et al., 2005; Herrick et al., 2011). In a school in Boston (U.S.) inhalation of PCBs 
leaching from caulking materials and sealants was determined as the main route of exposure 
for teachers. This exposure resulted in the teachers having a distinctive PCB signature, with 
proportions of the less chlorinated PCBs such as CB-8, CB-33, CB-37, CB-41, CB-47 and 
CB-136 up to five times higher than the control group (Herrick et al., 2011). In this current 
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study, participants with a positive score on PC1 and negative score on PC2 had a signature 
similar to A1260, but with the addition of high proportions of several less chlorinated PCBs 
such as CB-28, CB-60, CB-66 and CB-74, along with CB-105 and CB-118. This group was 
comprised of participants who all had different ages, jobs and years at the company. The 
signatures all contained higher proportions of more volatile PCBs which have been 
previously linked to indoor air sources such as leaching from sealants and caulking materials 
(Harrad et al., 2005; Herrick et al., 2011; Kohler et al., 2005). Several of the congeners 
present in higher proportions (CB-28, CB-60 and CB-66 and CB-74) have also been linked to 
exposure from capacitors in electrical equipment (Luotamo et al., 1993). Concentrations of 
PCBs in individuals from this group were similar to those from the group with prolonged 
exposure to A1260. Therefore, the results indicate that this group was exposed to an 
additional source of PCBs through inhalation, possibly originating from leaching of materials 
at the home rather than from their workplace (Figure 2).  
3.3.4 Enantiomeric fractions  
To further elucidate the potential sources of exposure to these individuals we also examined 
the enantiomer signatures of thee chiral PCBs (CB-95, CB-136 and CB-149) in the samples 
to ascertain if there were any trends in enantio-specific processing of these congeners that 
could be related to variations in the exposure of the workers, as well as potentially providing 
further insight into the pharmacokinetics of these pollutants in humans. To our knowledge 
this is the first time that analysis of this type has been done for human serum samples despite 
the widespread use of this matrix in human bio-monitoring programs (e.g. Canadian Health 
Measures Survey, United Sates Human Bio-monitoring Program). 
The enantiomeric fractions of CB-95 and CB-149 recorded in the workers varied 
considerably (0.41 to 0.91 and 0.21 to 0.48, respectively), whereas fractions of CB-136 
remained close to racemic (0.43 to 0.59) (Table 1). For CB-95 sera from most participants 
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contained higher proportions of the E1 or (+) enantiomer than the E2 or (-) enantiomer, 
indicating that significant enantioselective metabolism, elimination or sequestration of this 
enantiomer may have occured. In one worker (S029)  the proportion of E1 enantiomer was 
over 10 times greater than the E2 enantiomer. This mirrors the work of Chu et al. (2003) who 
found similar results for CB-95 in human liver samples. However in this current study the 
extent of change was much greater than was reported in Chu et al. (2003), with the results 
showing evidence of near complete removal of the E2 enantiomer in some participants. For 
CB-149 sera from all participants contained higher proportions of E2. In one worker the 
proportion of E2 was over 3.5 times greater than E1 (S014). 
No clear trends in enantiomeric signatures with the exposure type or duration of work were 
identified in this study (Figure 5). However, there was a weak correlation between the EFs of 
CB-95 and CB-149 with EC7 PCB concentrations (Figure 5). Participants with higher PCB 
concentrations tended to display a greater degree of enrichment of the E1 enantiomer of CB-
95 (P-value 0.139) and E2 enantiomer of CB-149 (P-value 0.026). This suggests that there 
may be a concentration dependent element to the metabolism of these congeners in humans. 
The high varability in the data for these two congeners also indicates that there is signifcant 
intra-individual variation in the enantiospecific processing of these contaminants.  
Importantly these data also indicate that PCB profiles measured in sera may not fully match 
those found in other bodily tissues. The data recorded here are in contrast to those recorded 
by Chu et al. (2003) for CB-95, CB-132 and CB-149 in human muscle, kidney and brain 
samples that were all racemic or nearly racemic. However, they do match those recorded by 
Chu et al. (2003) for liver samples which were largely non-racemic in nature. This suggests 
that sera may in fact reflect liver profiles only, rather than whole body signatures. This has 
potentially important implications for sera based human biomonitoring programs such as the 
Canadian Health Measures Survey (CHMS) and the National Health and Nutrition 
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Examination Survey (NHANES) as it suggests that they may underestimate the true PCB 
burden and profiles of subjects. However, further work is needed to confirm this hypothesis. 
These data also suggest that the enantiomeric profile of the PCBs should be taken into 
account when assessing the toxicity of any potential exposure as the persistance and 
consequent effects of the enantiomers and their metabolic products may be significantly 
different (Kodavanti and Curras-Collazol, 2010). This is especially relevant for CB-95 which 
exhibits the highest potency and efficacy towards the ryanodine receptor which has been 
linked to developmental neurotoxicity (Schantz et al. 1997). 
 
Figure 5. Enantiomer Fraction of CB-95 (Figure 5A), CB-136 (Figure 5B) and CB-149 
(Figure 5C), and their relationship with EC7 PCB concentrations and the groups 
identified by PCA. The red line on the scatter plots represents an EF of 0.5 (i.e. a 
racemic mixture). Box plots display the interquartile range, median and mean (•). 
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4 Conclusions 
Identifying the source and age dating human exposure to PCBs is a highly complex task. This 
is due to the wide range of PCB sources that humans are exposed to along with different 
exposure pathways and processes such as volatilization, dissolution, biodegradation and post 
uptake processes that can all alter the original PCB signature. However, by considering PCB 
concentrations along with detailed congener specific signatures it was possible to identify 
different sources, and gain an insight into both the magnitude and duration of exposure. 
Occupationally exposed individuals had a similar PCB profile to Aroclor A1260. Individuals 
with prolonged exposure had depleted proportions of several PCB congeners that are 
susceptible to metabolism (CB-95, CB-101 and CB-151), and elevated proportions of PCBs 
that are resistant to metabolism (CB-74, CB-153, CB-138 and CB-180). A group of workers 
was also identified with a suspected additional source of exposure through the inhalation of 
PCBs, as their sera contained elevated proportions of CB-28, CB-60, CB-66, CB-74, CB-105 
and CB-118. 
Whilst there were no clear trends in enantiomer signatures with the exposure type and 
duration identified in this study, there was a weak correlation between the EFs of CB-95 and 
CB-149 with EC7 PCB concentrations, suggesting that there may be a concentration 
dependent element to the metabolism of these congeners in humans. The extent of 
enantioselective metabolism or excretion in several workers was so great it resulted in the 
near complete removal the E2 enantiomer. 
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